DCZ5418
Product Specifications
UNSPSC Description
DCZ5418 is an inhibitor of TRIP13. DCZ5418 has anti-multiple myeloma activity in vitro and in vivo[1].
Target Antigen
Apoptosis; NF-κB
Type
Reference compound
Related Pathways
Apoptosis;NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dcz5418.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1C2=CC=C(C=C2)CC3=CC=NC=C3)[C@@]4(C)[C@@]([C@@H]5CC[C@H]4O5)(C)C1=O
Molecular Weight
362.42
References & Citations
[1]Sanfeng Dong, et al. Design and synthesis of cantharidin derivative DCZ5418 as a TRIP13 inhibitor with anti-multiple myeloma activity in vitro and in vivo. Bioorg Med Chem Lett. 2023.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-157331/DCZ5418-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-157331/
Clinical Information
No Development Reported
CAS Number
2883709-99-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6334101-01 0.2 mL
PIK3R4, ID (PIK3R4, Phosphoinositide 3-kinase regulatory subunit 4, PI3-kinase p150 subunit, Phosphoinositide 3-kinase adaptor protein) (PE)
Ask
View Details MBS6334101-02 5x 0.2 mL
PIK3R4, ID (PIK3R4, Phosphoinositide 3-kinase regulatory subunit 4, PI3-kinase p150 subunit, Phosphoinositide 3-kinase adaptor protein) (PE)
Ask
View Details